Clinical trial
Dronabinol Naltrexone Treatment for Opioid Dependence
NCT01024335 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dronabinol Naltrexone Treatment for Opioid Dependence
- Lead sponsor
- New York State Psychiatric Institute
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- December 31, 2012
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
opioid dependence